异常的非正规NF-κB信号重新编程表观基因组格局,以驱动多发性骨髓瘤中的瘤转录组
Daniel A Ang1, Jean-Michel Carter1, Kamalakshi Deka1
1School of Biological Sciences (SBS), Nanyang Technological University (NTU), 60 Nanyang Drive, Singapore, 637551, Singapore.
Nature communications
|March 22, 2024
概括
多发性骨髓瘤中异常的非正规NF-κB信号通过重编程表观基因组驱动癌症的进展. 这项研究确定了p52依赖增强剂和RGS1作为关键驱动因素,揭示了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 多发性骨髓瘤涉及异常的血细胞,在骨髓中形成瘤.
- 激活NF-κB通路对于血细胞生存和增殖至关重要.
- 遗传突变可以导致骨髓瘤中构成NF-κB的激活.
研究的目的:
- 调查持续的NF-κB/p52水平如何影响多发性骨髓瘤中增强剂的招募.
- 描述p52在超强增强剂形成和cis调节相互作用中的作用.
- 以功能验证这些调节模块对髓瘤表型的影响.
主要方法:
- 针对p52的有针对性的破坏,以分析增强剂的招募和超级增强剂的形成.
- 在体外和体外模型评估cis-regulatory模块的病理影响.
- 对转录程序和细胞表型的分析.
主要成果:
- 持续的NF-κB/p52水平促进了非正规增强剂的招募.
- p52的破坏抑制了超强增强剂的形成,并改变了 cis 调节相互作用.
- RGS1被确定为多发性骨髓瘤进展的p52依赖驱动因素.
- 异常的表观基因组重编程支持髓瘤细胞生存和瘤生长.
结论:
- 异常的非正规NF-κB信号驱动在多发性髓瘤中的表观基因组重编程.
- 对p52依赖的增强剂和cis调节模块对于髓瘤的进展至关重要.
- 针对这些途径,包括RGS1,可能为多发性骨髓瘤提供新的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K


